BEAMER

Starts: 01/09/21
Ends: 31/08/26

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

project-logo-beamer

Scope and objectives

The BEAMER’s vision is to improve the quality of life of individuals, enhance healthcare accessibility and sustainability, thereby transforming the way healthcare stakeholders engage with patients to understand their condition and adherence levels throughout their healthcare journey. An outstanding experienced consortium supports the BEAMER vision with the following specific objectives organized in four phases. These objectives are fully aligned to the IMI Call topic.

ECHAlliance role

The ECHAlliance is the Communications Dissemination Manager of BEAMER; leading the task 6.7. Communications & Dissemination.

Consortium

Led by Pfizer, co-led by Merck KGaA (Darmstadt, Germany) and coordinated by Universidad Politécnica de Madrid (UPM) the five-year project – “BEhavioral and Adherence Model for improving quality, health outcomes and cost-effectiveness of healthcaRe (BEAMER)” – brings together 27 European partners from academia, civil society and industry to jointly address adherence to treatment.